Shilpa Patere
Post-Doctoral Fellow
GSK
Education
2000-2004 Bachelors in Pharmaceutical Sciences University of Mumbai, India
2005-2008 Masters (Pharmacology) University of Mumbai, India
2009-2014 PhD. (Pharmaceutics) University of Mumbai, India
Professional Appointments
Jan 2009-May 2009 Research Associate (Formulation), S. Zhaveri Pharmakem Pvt. Ltd, Mumbai, India
Professional Societies
2006-2007 Member of Indian Pharmaceutical Association (IPA)
2009-2013 Member of Indian Pharmaceutical Association (IPA)
2011 Member of Controlled Release Society (CRS)
2015 Member of American Association of Pharmaceutical Scientists (AAPS)
Honors and Awards
2002-2003 Ratan Tata Trust Scholarship for excellent academic performance
2005-2006 Ratan Tata Trust Scholarships for excellent academic performance
2009-2012 University Grant Commission (UGC) research fellowship
2011 Prof. M. L. Khorana best paper award for the research paper published in Indian Journal of Pharmaceutical Sciences
Presentations
‘Influence of excipients on physicochemical characteristics of ocular semisolid formulations and their in vitro drug release’ at AAPS Annual Meeting and Exposition – 2015 Orlando, FL, USA
‘Surface modified liposomal formulation of Amphotericin B for treatment of visceral leishmaniasis’ at 6th International Conference organized by South Asian Chapter- American College of Cinical Pharmacology (SAC-ACCP)-2013 Mumbai, India
‘Liposomal drug delivery system for receptor based hepatic targeting’ at 38th Annual Meeting and Exposition of The Controlled Release Society-2011 Maryland, USA
‘Compritol® 888ATO a release modifier for sustained release of highly water soluble agent: Formulation, Evaluation and IVIVC study’ at 38th Annual Meeting and Exposition of The Controlled Release Society-2011 Maryland, USA
‘Positively charged polymeric nanoparticles of poorly water soluble drug Meloxicam’ at 10th International symposium on advances in technology and business potential of new drug delivery systems, February 2010, Mumbai, India.
‘Ethyl acetate fraction of Eclipta alba as inhibitor of Xanthine Oxidase and scavenger of superoxide anions’ at 58th Indian Pharmaceutical congress (IPC) held in Dec’ 06 at Mumbai.
Publications
N. Patere, P. O. Pathak, A.K. Shukla, R. K. Singh, V. K. Dubey, M. J. Mehta, A. G. Patil, V. Gota, M. S. Nagarsenker. Surface Modified Liposomal Formulation of Amphotericin B for In vitro Treatment of Visceral Leishmaniasis. AAPS PharmSciTech 2016 (Accepted) DOI: 10.1208/s12249-016-0553-8
N. Patere, C. J. Kapadia, M. S. Nagarsenker. Infuence of formulation factors and compression force on release profile of sustained release metoprolol tablets using compritol® 888ATO as lipid excipient. Indian Journal of Pharmaceutical Sciences 2015, 77(5), 620-625
N. Patere, N. S. Desai, A. S. Jain, M. S. Nagarsenker, P. P. Kadam, U. M. Thatte, N. J. Gogtay, C. J. Kapadia, N. Farah. Compritol® 888ATO a lipid excipient for sustained release of highly water soluble active: Formulation, scale-up and IVIVC study. Current Drug Delivery 2013, 10(5), 548-556
A. Date, M. S. Nagarsenker, S. N. Patere, V. V. Dhawan, R. P Gude, P. A. Hassan, V. K. Aswal, F. Steiniger, J. Thamm, and A. Fahr. Lecithin based novel cationic nanocarriers (Leciplex) II: Improving therapeutic efficacy of quercetin on oral administration. Molecular Pharmaceutics 2011, 8(3), 716-726
N. Patere, M. N. Saraf and A. S. Majumdar. Exacerbation of alcohol induced oxidative stress in rats by polyunsaturated fatty acids (PUFA) and iron load. Indian Journal of Pharmaceutical Sciences 2011, 73(2), 152-158
N. Patere, M. N. Saraf and A. S. Majumdar. Hepatoprotective activity of polyherbal formulation (Normeta®) in oxidative stress induced by alcohol, polyunsaturated fatty acids and iron in rats. Basic and Clinical Pharmacology and Toxicology 2009, 105, 173-180
A.S. Majumdar, M. N. Saraf, S. A. Mukherjee, S. N. Patere, N. R. Andrades, R. Y. Kamble. Xanthine oxidase inhibition and superoxide anion scavenging activity of Eclipta alba linn. Indian Drugs 2008, 45(10), 824-826
Patents
Indian patent application no 374/MUM/2010, titled “Novel particulate composite systems for targeted drug delivery”.
Indian patent application no. 1956/MUM/2010, titled “Novel cationic lipids for delivery of bioactives”.
